Clinical trial
Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
NCT00490542 · Tufts Medical Center, Other · Completed
Key facts
| NCT number | NCT00490542 |
|---|---|
| Title | Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State |
| Official title | Double-blind, Placebo-controlled Trial of Ziprasidone (Geodon) for the Depressive Mixed State |
| Lead sponsor | Tufts Medical Center, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Bipolar Depression, Depression |
| Intervention type | Drug |
| Interventions | ziprasidone (Geodon), placebo |
| Enrollment | 73 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 22, 2007 |
| Last update posted | Jul 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: